10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 4, Pages 1125
Publisher
MDPI AG
Online
2023-02-10
DOI
10.3390/cancers15041125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis
- (2023) Andrea Di Giorgio et al. Cancers
- Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases
- (2022) Aurélie Balmer et al. Cancers
- Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial
- (2022) Andrew R Clamp et al. LANCET ONCOLOGY
- Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
- (2022) Wim Ceelen et al. EBioMedicine
- Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases
- (2021) Nicolas Tabchouri et al. ANNALS OF SURGICAL ONCOLOGY
- Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)
- (2021) Koen P. Rovers et al. ANNALS OF SURGICAL ONCOLOGY
- A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis
- (2021) Manuela Robella et al. Cancers
- Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer
- (2021) Linda Feldbrügge et al. Frontiers in Oncology
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. Systematic Reviews
- Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer
- (2021) Rémy Sindayigaya et al. ANNALS OF SURGICAL ONCOLOGY
- Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review
- (2020) Magnus Ploug et al. BMC CANCER
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study
- (2020) S. Bremholm Ellebæk et al. CLINICAL & EXPERIMENTAL METASTASIS
- Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC
- (2020) Malene Nielsen et al. JOURNAL OF CLINICAL PATHOLOGY
- Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center
- (2020) C. Ceribelli et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial
- (2020) Robin J. Lurvink et al. ANNALS OF SURGICAL ONCOLOGY
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer
- (2020) Mohammad Alyami et al. EJSO
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial
- (2020) Michele De Simone et al. Biomedicines
- Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis
- (2020) Andrea Di Giorgio et al. SURGICAL ONCOLOGY-OXFORD
- Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases
- (2020) Abdelkader Taibi et al. ANNALS OF SURGICAL ONCOLOGY
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer
- (2020) Günther A. Rezniczek et al. BMC CANCER
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative study
- (2019) Matthieu Siebert et al. EJSO
- Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study
- (2019) Olivia Sgarbura et al. EJSO
- Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- (2019) Mohammad Alyami et al. EJSO
- Safety and preliminary efficacy of electrostatic precipitation during pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable carcinomatosis
- (2019) W. Willaert et al. EJSO
- Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
- (2019) Mohammad Alyami et al. LANCET ONCOLOGY
- Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient
- (2019) Martin Graversen et al. EJSO
- Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer
- (2019) Ines Gockel et al. TUMORI
- A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis
- (2018) Clemens B. Tempfer et al. GYNECOLOGIC ONCOLOGY
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer
- (2018) Philipp Horvath et al. CLINICAL & EXPERIMENTAL METASTASIS
- Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study
- (2018) Florian Kurtz et al. Gastroenterology Research and Practice
- Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis
- (2017) Ziad Hilal et al. Journal of Gynecologic Oncology
- Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer
- (2017) Salah-Eddin Al-Batran et al. JAMA Oncology
- Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma
- (2017) Tanja Khosrawipour et al. PLoS One
- Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
- (2016) Jan Franko et al. LANCET ONCOLOGY
- Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis
- (2016) Manuela Robella et al. World Journal of Surgical Oncology
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- (2016) Ramy Girshally et al. World Journal of Surgical Oncology
- Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
- (2015) K. Odendahl et al. EJSO
- Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study
- (2015) Clemens B. Tempfer et al. GYNECOLOGIC ONCOLOGY
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
- (2015) Giorgi Nadiradze et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
- (2013) Wiebke Solass et al. ANNALS OF SURGICAL ONCOLOGY
- Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: Preliminary clinical experience
- (2013) Clemens B. Tempfer et al. GYNECOLOGIC ONCOLOGY
- 2013 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Baltimore, Maryland, USA, 17–20 April 2013
- (2013) SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now